Trials / Completed
CompletedNCT06251882
Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia
6-month Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | injection | 10ml D5W injection for MP patients |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-06-30
- Completion
- 2024-01-30
- First posted
- 2024-02-09
- Last updated
- 2024-02-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06251882. Inclusion in this directory is not an endorsement.